Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension

Repeatability of Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IV-US) in Pulmonary Arterial Hypertension

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03105934

Enrollment

Registered

2017-04-10

Start date

2016-04-30

Completion date

2018-01-25

Last updated

2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Arterial Hypertension

Brief summary

To assess the correlation between pulmonary IV-OCT and pulmonary IV-US measurements and standard PAH clinical measures of disease progression and the relative sensitivity of the techniques to change.

Interventions

PROCEDUREPatients with Pulmonary Arterial Hypertension

2 repeated measurement session to enable assessment of technical and medium-term reproducibility of IV-US and IV-OCT.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* With confirmed diagnosis of PAH Group 1 according to the ESC/ERS Guidelines * With severe disease, defined as Class II- III of the modified WHO functional classes in the ESC/ERS Guidelines

Exclusion criteria

* That according to investigator criteria cannot participate in the trial

Design outcomes

Primary

Measure	Time frame	Description
Image measurements	12 months	Repeat acquisitions to be made in the same regions and in locations

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026